Max is a partner at VHPM. Before joining the firm in 2023, Max was Vice President of Intellectual Property at Lexicon Pharmaceuticals, where he formulated and implemented patent, trademark, and life-cycle management strategies for Lexicon’s platform technologies, antibodies, antibody conjugates, and small molecule drug candidates. Before Lexicon, Max litigated and prosecuted patents for a variety of clients in the biotechnology and pharmaceutical industries. When not at work, Max enjoys spending time with his family, playing guitar, and running.
Max’s favorite place to spend the summer: The Oregon coast